HomeFinanceA good growth...

A good growth outlook is seen for Context Therapeutics Inc. (CNTX) Stock by analysts

The latest trade, Performances and Moving Averages give us the following Picture

The share price of Context Therapeutics Inc. (NASDAQ:CNTX) raised 13.18% to close Wednesday’s market session at $0.79, higher as compared to yesterday’s close. The stock price fluctuated between $0.6406 and $0.91 throughout the trading session with the volume trading being 900982 shares, which represented a significant variation when compared to the three months average volume of 94.97K shares. The firm’s stock price fluctuated 44.64% within the last five trades and 36.99% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -37.80% in the last 6 months and -0.39% was subtracted to its value over the previous 3 months. CNTX stock is trading at a margin of 37.85%, 31.21% and -21.97% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, CNTX deals in the Healthcare domain. The stock is trading -68.65 percent below its 52-week high and 68.09 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -47.53. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


What Does Context Therapeutics Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $10.83 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The firm managed a Price-to-Book ratio of 0.44, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.90 percent of Context Therapeutics Inc. shares are owned by insiders, and 32.50 percent are held by financial institutions. Lehr Martin A., the Chief Executive Officer at Context Therapeutics Inc. (CNTX) has bought 5,823 shares of firm on Feb 21 at a price of $0.84 against the total amount of $4900.0. In another inside trade, Lehr Martin A., Chief Executive Officer of Context Therapeutics Inc. (NASDAQ:CNTX) bought 5,606 shares of the firm on Feb 13 for a total worth of $4901.0 at a price of $0.87. An inside trade which took place on Feb 06, Chief Executive Officer of Context Therapeutics Inc. Lehr Martin A. bought 5,040 shares of firm against total price of $4900.0 at the cost of $0.97 per share.



Please enter your comment!
Please enter your name here

Recent Post